Community Research and Development Information Service - CORDIS

H2020

anTBiotic

Project ID: 733079
Funded under

AnTBiotic – progressing TB drug candidates to clinical proof of concept

From 2017-01-01 to 2021-12-31, ongoing project

Project details

Total cost:

EUR 5 819 416

EU contribution:

EUR 5 819 416

Coordinated in:

Spain

Call for proposal:

H2020-SC1-2016-RTDSee other projects for this call

Funding scheme:

RIA - Research and Innovation action

Objective

Coordinator

GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL
Spain

EU contribution: EUR 1 923 768


C/ SANTIAGO GRISOLIA 4
28760 TRES CANTOS
Spain
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Participants

UNIVERSITETET I TROMSOE
Norway

EU contribution: EUR 644 072,50


HANSINE HANSENS VEG 14
9019 TROMSO
Norway
Activity type: Higher or Secondary Education Establishments
FORSCHUNGSZENTRUM BORSTEL
Germany

EU contribution: EUR 1 242 417,50


Parkallee 1-40
23845 BORSTEL
Germany
Activity type: Research Organisations
UNIVERSITY OF CAPE TOWN
South Africa

EU contribution: EUR 135 353,75


PRIVATE BAG X3
7701 RONDEBOSCH
South Africa
Activity type: Higher or Secondary Education Establishments
TASK FOUNDATION NPC
South Africa

EU contribution: EUR 1 873 804,25


M2 KARL BREMER HOSPITAL MIKE PIENAAR BOULEVARD BELLEVILLE
7530 CAPE TOWN
South Africa
Activity type: Other
Record Number: 207216 / Last updated on: 2017-01-11
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top